Skip to content

Relmada Therapeutics, Inc. RLMD Professional service fees

Professional service fees at other companies

Arvinas logo
ArvinasARVN
Replimune Group logo
Replimune GroupREPL
Nuvation Bio logo
Nuvation BioNUVB
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Neuropace, Inc. logo
Neuropace, Inc.NPCE

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s professional service fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s professional service fees?
Relmada Therapeutics, Inc. (RLMD) reported professional service fees of $312.9K in Q1 2026.
How has Relmada Therapeutics, Inc.'s professional service fees changed year-over-year?
Relmada Therapeutics, Inc.'s professional service fees decreased by 0.1% year-over-year, from $313.2K to $312.9K.
What is the long-term trend for Relmada Therapeutics, Inc.'s professional service fees?
Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s professional service fees has grown at a 7.8% compound annual growth rate (CAGR), from $150.9K to $220K.